1-(4-tert-butyl-benzoyl)-3-phenyl-thiourea | 125911-12-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-tert-butyl-benzoyl)-3-phenyl-thiourea
• 英文别名: 4-tert-butyl-N-(phenylcarbamothioyl)benzamide
• CAS: 125911-12-8
• 化学式: C₁₈H₂₀N₂OS
• 分子量: 312.436
• InChiKey: LAAXVMKAZUZGRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  73.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  苯胺 、 4-(tert-butyl)-benzoyl isothiocyanate 以 丙酮 为溶剂， 反应 2.0h， 生成 1-(4-tert-butyl-benzoyl)-3-phenyl-thiourea
  参考文献：
  名称：

  SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activity

  摘要：

  A series of acylthiourea derivatives were designed, synthesized, and evaluated for broad-spectrum antiviral activity with selected viruses from Poxviridae (vaccinia virus) and two different genera of the family Bunyaviridae (Rift Valley fever and La Crosse viruses). A compound selected from a library screen, compound 1, displayed submicromolar antiviral activity against both vaccinia virus (EC50 = 0.25 mu M) and La Crosse virus (EC50 = 0.27 mu M) in cytopathic effect (CPE) assays. SAR analysis was performed to further improve antiviral potency and to optimize drug-like properties of the initial hits. During our analysis, we identified 26, which was found to be nearly fourfold more potent than 1 against both vaccinia and La Crosse viruses. Selected compounds were further tested to more fully characterize the spectrum of antiviral activity. Many of these possessed single digit micromolar and sub-micromolar antiviral activity against a diverse array of targets, including influenza virus (Orthomyxoviridae), Tacaribe virus (Arenaviridae), and dengue virus (Flaviviridae). (C) 2012 Elsevier Ltd. All rights

  DOI：

  10.1016/j.bmcl.2012.05.035

文献信息

• NOVEL THIOUREA OR UREA DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS, CONTAINING SAME AS ACTIVE INGREDIENT
  申请人：You Ji Chang

  公开号：US20130096138A1

  公开（公告）日：2013-04-18

  Disclosed are novel thiourea or urea derivatives inhibitory of HIV activity. Also provided are a method for preparing the thiourea or urea derivatives, and a pharmaceutical composition for the prophylaxis or therapy of AIDS comprising the derivatives. Having high inhibitory activity against HIV, the thiourea or urea derivatives can be effectively used in the prophylaxis or therapy of AIDS.

  本文披露了一种新颖的硫脲或脲衍生物，具有抑制HIV活性的作用。还提供了一种制备硫脲或脲衍生物的方法，以及一种包含这些衍生物的用于预防或治疗艾滋病的药物组合物。由于硫脲或脲衍生物具有高抑制HIV活性，因此可以有效地用于艾滋病的预防或治疗。
• [EN] INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS<br/>[FR] INHIBITEURS ET PROCÉDÉS D'INHIBITION DE PATHOGÈNES BACTÉRIENS ET VIRAUX
  申请人：SIGA TECHNOLOGIES INC

  公开号：WO2011103375A1

  公开（公告）日：2011-08-25

  Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed.

  本发明涉及化合物、药物组合物和治疗病毒和细菌感染的方法，通过给予一定量的硫脲化合物，特别是酰基硫脲、羧酰亚硫脲和S-烷基异硫脲衍生物和类似物，以治疗有效量的方法。
• Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens
  申请人：Allen Robert D.

  公开号：US20130195796A1

  公开（公告）日：2013-08-01

  Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed.

  本发明涉及一种使用某些硫脲化合物（具体为酰硫脲、羧基亚硫脲和S-烷基异硫脲衍生物和类似物）以治疗病毒和细菌感染的药物组合物和方法，通过以治疗有效剂量进行给药。
• INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS
  申请人：SIGA TECHNOLOGIES, INC.

  公开号：US20160081950A1

  公开（公告）日：2016-03-24

  Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed.

  本发明涉及一种治疗病毒和细菌感染的化合物、药物组合物和方法，通过给予一些硫脲化合物，特别是酰基硫脲、羧酸亚胺基硫脲和S-烷基异硫脲衍生物和类似物，在治疗有效的剂量下进行治疗。
• Inhibitors and methods of inhibiting bacterial and viral pathogens
  申请人：Siga Technologies, Inc.

  公开号：EP2865668A2

  公开（公告）日：2015-04-29

  Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed.

  本发明公开了治疗病毒和细菌感染的化合物、药物组合物和方法，通过施用某些硫脲化合物，特别是酰基硫脲、羧酰亚胺基硫脲和 S-烷基异硫脲衍生物及类似物，达到治疗有效量。